Phyllanthus spp. induces selective growth inhibition of PC-3 and mewo human cancer cells through modulation of cell cycle and induction of apoptosis

PLoS ONE

Volumn 5, Issue 9, 2010, Pages 1-11

  Tang, Yin Quan ^a   Jaganath, Indu Bala ^b   Sekaran, Shamala Devi ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

^b MALAYSIAN AGRICULTURAL RESEARCH AND DEVELOPMENT INSTITUTE MARDI   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 7; DOXORUBICIN; ELLAGITANNIN; FLAVONOID; FLUOROURACIL; LACTATE DEHYDROGENASE; METHANOL; PHYLLANTHUS AMARUS EXTRACT; PHYLLANTHUS NIRURI EXTRACT; PHYLLANTHUS URINARIA EXTRACT; PHYLLANTHUS WATSONII EXTRACT; PLANT EXTRACT; TANNIN; UNCLASSIFIED DRUG; WATER; GROWTH INHIBITOR;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DNA FRAGMENTATION; DRUG CYTOTOXICITY; DRUG DETERMINATION; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; MELANOMA; NICK END LABELING; PHYLLANTHUS; PHYLLANTHUS NIRURI; PHYLLANTHUS URINARIA; PHYLLANTHUS WATSONII; PROSTATE CANCER; CELL CYCLE; CHEMISTRY; DRUG EFFECT; MALE; PATHOPHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GROWTH INHIBITORS; HUMANS; MALE; MELANOMA; PHYLLANTHUS; PLANT EXTRACTS; PROSTATIC NEOPLASMS;

EID: 77958556051     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0012644     Document Type: Article

References (47)

1. Sun J, Liu RH (2005) Cranberry photochemical extracts induce cell cycle arrest and apoptotsis in human MCF-7 breast cancer cells. Cancer Lett 241: 124-134.
2. Wingo P, Tong T, Bollden S (1995) Cancer Statistics. CA Cancer J Clin 45: 8-30.
3. American Cancer Society (2009) Cancer Facts & Figures 2009. Atlanta: ACS. Pp 19-20.
4. Cancer Research UK (2010) Skin cancer - UK incidence statistic. Cancer Research UK. Available: http://info.cancerresearchuk.org/cancerstats/types/skin/incidence/. Accessed 2010 Apr 1.
5. Shoeb M (2006) Anticancer agents from medicinal plants. Bangledesh J Pharmacol 1: 35-41.
6. Varma A, Padh H, Shrivastava N (2009) Andrographolide: A new plant-derived antineoplastic entity on Horizon. eCAM, In press.
7. Cragg GM, Newman DJ (2005) Plants as a source of anti-cancer agents. J Ethnopharmacol 100: 72-79.
8. nd Ed. Florida: Taylor & Francis Group. 334 p.
9. Blumberg BS, Millman I, Venkeatswaran PS, Thyagarajan SP (1990) Hepatitis B virus and primary hepatocellular carcinoma: Treatment of HBV carriers with Phyllanthus amarus. Vaccine 8: S86-S92.
10. Venkateswaran PS, Millman I, Blumberg BS (1997) Effects of an extracts from Phyllanthus niruri on hepatitis B and woodchuck hepatitis virus: in vitro and in vivo studies. Proc Natl Acad Sci 84(1): 274-278.
11. Lee CD, Ott M, Thygarajan SP, Shfritz DA, Burk RD, et al. (1996) Phyllanthus amarus down-regulates hepatitis B virus mRNA transcription and translation. Eur J Clin Invest 26: 1069-1076.
12. Ott M, Thyarajan SP, Gupta S (1997) Phyllanthus amarus suppress hepatitis B virus interrupting interactions between HBV enhancer I and cellular transcription factors. Eur J Clin Invest 11: 908-915.
13. Mazumder A, Mahato A, Mazumder R (2006) Antimicrobial potentially of Phyllanthus amarus against drug resistant pathogens. Nat Prod Res 20: 323-326.
14. Kloucek P, Polesny Z, Svobodova B, Vlkova E, Kokoska L (2005) Antibacterial screening of some Peruvian medicinal plants used in Calleria District. J Ethnopharmacol 99: 309-312.
15. Zhou S, Xu C, Zhou N, Huang Y, Huang L, et al. (1997) Mechanism of protective action of Phyllanthus niruri L. against injuries of liver cells. Zhongguo Zhong Yao Za Zhi 22(2): 109-111.
16. Rajeshkumar NV, Joy KL, Kuttan G, Ramsewak RS, Nair MG, et al. (2002) Antitumour and anticarcinogenic activity of Phyllanthus amarus extract. J Ethnopharmacol 81: 17-22.
17. Jeena KJ, Joy KL, Kuttan R (1999) Effects of Emblica officinalis, Phyllanthus amarus and Picrorrhiza Kurroa on N-nitrosodiethylamine induced hepatocarcinogn-esis. Cancer Lett 136: 11-16.
18. Prakash A, Satyan KS, Wahi SP, Sing RP (2006) Comparative hepatoprotective activity of three Phyllanthus species, P. urinaria, P. niruri and P. simplex, on carbon tetrachloride induced liver injury in the rat. Phytotherapy Res 9(8): 594-596.
19. Asha VV, Sheeba MS, Suresh V, Wills PJ (2007) Hepatoprotection of Phyllanthus maderaspatensis against experimentally induced liver injury in rats. Fitoterapia 78(2): 134-141.
20. Rajeshkumar NV, Kuttan R (2000) Phyllanthus amarus extract administration increases the life span of rats with hepatocellular carcinoma. J Ethnopharmacol 73: 215-219.
21. Mazunder UK, Gupta M, Rajeshwar Y (2005) Antihyperglcemic effect and antioxidant potential of Phyllanthus niruri in streptozotocin induced diabetic rats. Eur Bull Drug Res 13: 15-23.
22. Raphael KR, Ajith TA, Joseph S, Kuttan R (2002) Hypoglycemic effect of methanol extract of Phyllanthus amarus Schum and Thonn on alloxan induced diabetes mellitus in rats and its relation with antioxidant potential. Ind J Exp Biol 40: 905-909.
23. Kasibhatla S, Tseng B (2003) Why target apoptosis in cancer treatment? Mol Cancer Ther 2: 573-80.
24. Kastan MB, Bartek J (2004) Cell-cycle checkpoints and cancer. Nature 432: 316-23.
25. Ren W, Qiao Z, Wang H, Zhu L, Zhang L (2003) Flavonoids: promising anticancer agents. Med Res Rev 23: 519-534.
26. Faried A, Kurnia D, Faried LS, Usman N, Miyazaki T, et al. (2007) Anticancer effects of gallic acid isolated from Indonesian herbal medicine, Phaleria macrocarpa (Scheff.) Boerl, on human cancer cell lines. Int J Oncol 30: 605-613.
27. Jin UH, Lee JY, Kang SK, Park WH, Kim JH, et al. (2005) A phenolic compound, 5-caffeolquinic acid (chlorogenic acid) is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus. Life Sci 77(22): 2760-2769.
28. Huang ST, Yang RC, Chen MY, Pang JHS (2004) Phyllanthus urinaria induces the Fas receptor/ligand expression and ceramide-mediated apoptotsis in HL-60 cells. Life Sci 75: 339-351.
29. Schwartz GK, Shah MA (2005) Targeting the cell cycle: A new approach to cancer therapy. J Clin Oncol 23: 9408-9421.
30. Mailand N, Falck J, Lukas C, Syljuâsen RG, Welcker M, et al. (2000) Rapid destruction of human Cdc25A in response to DNA damage. Science 288(5470): 1425-1429.
31. Molinari M, Mercurio C, Dominguez J, Goubin F, Draetta GF (2000) Human Cdc2A inactivation in response to S phase inhibition and its role in preventing premature mitosis. EMBO Reports 1: 71-79.
32. Madson JG, Lynch DT, Svoboda J, Ophardt R, Yanagida J, et al. (2009) Erbb2 Suppresses DNA Damage-Induced Checkpoint Activation and UV-Induced Mouse Skin Tumorigenesis. Am J Pathol 174(6): 2357-2366.
33. Puri N, Eller MS, Byers HR, Dykstra S, Kubera J, et al. (2004) Telomere-based DNA damage responses: A new approach to melanoma. FASEB J 18: 1373-1381.
34. Maecker HL, Koumenis C, Giaccia AJ (2000) P53 promotes selection for Fasmediated apoptotic resistance. Cancer Res 60: 4638-4644.
35. Zhang Z, Li M, Agrawal S, Zhang RW (2003) Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation apoptosis, multiple gene expression, and chemotherapy. Proc Natl Acad Sci 100(20): 11636-11641.
36. Che XH, Park EJ, Zhao YZ, Kim WH, Sohn DW (2009) Tanshinone IIA induces apoptosis and S phase cell cycle arrest in activated rat hepatitc stellate cells. Basic Clin Pharmacol Toxicol 106: 30-37.
37. Lansky EP, Jiang W, Mo H, Bravo L, Froom P, et al. (2005) Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs 23: 11-20.
38. Baek SJ, Kim JS, Jackson FR, Eling TE, McEntee MF, et al. (2004) Epicatechin gallate-induced expression of NAG-1 is associated with growth inhibition and apoptosis in colon cancer cells. Carcinogenesis 25(12): 2425-2432.
39. Hastak K, Agarwal MK, Mukhtar H, Agarwal ML (2005) Ablation of either p21 or Bax prevents p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate. FASEB J 19: 789-791.
40. Zhou MX, Gu LB, Li FZ, Zhu YR, Woods WG, et al. (2002) DNA damage induces a novel p53-survivin signalling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Therapeut 303(1): 124-131.
41. Kim SJ, Park KM, Kim NY, Yeom YI (2006) Doxorubicin prevents endoplasmic reticulum stress-induced apoptosis. Biochem Biophys Res Commun 339: 463-468.
42. Soini Y, Pääkkö P, Lehto VP (1998) Histopathological evaluation of apoptosis in cancer. Am J Pathol 154(4): 1041-1053.
43. Fan TJ, Han LH, Cong RS, Liang J (2005) Caspase Family Proteases and Apoptosis. Acta Biochim Biophys Sin 37(11): 719-727.
44. Ji BC, Hsu WH, Yang JS, Hsia TC, Lu CC, et al. (2009) Gallic acid induces apoptosisi via caspase-3 and mitochondrion-depedent pathways in vitro and suppresses lung xenograft tumor growth in vivo. J Agric Food Chem 57(16): 7596-7604.
45. Guchelaar HJ, Uges DRA, de Vries EGE, Oosterhuis JW, Mulder NH (1992) Combination therapy with cisplatin: Modulation of activity and tumour sensitivity. Clin Oncol 4(6): 388-393.
46. Mailloux A, Grenet K, Bruneel A, Bénéteau-Burnat B, Vaubourdolle M, et al. (2001) Anticancer drugs induce necrosis of human endothelial cells involving both oncosis and apoptosis. Eur J Cel Biol 80(6): 442-449.
47. Deichmann M, Benner A, Bock M, Jäckel A, Uhl K, et al. (1999) S100-Beta, melanoma-inhibiting activity, and lactate dehydrogenase discriminate progressive from nonprogressive American joint committee on cancer stage IV melanoma. J Clin Oncol 17(6): 1891-1896.